Skip to content

Gregor Gryglewski

3 papers in the library · 17 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry

European Psychiatry June 23, 2026 Maximilian Preiß, Valentin Popper, Luna Helene Charlotte Faber et al.

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Oral Ketamine for the Treatment of Depression: A randomized controlled trial and meta-analysis

medRxiv Preprint Server March 21, 2025 Leo R. Silberbauer, Benjamin Eggerstorfer, Paul Michenthaler et al. 1 citation preprint

Background Ketamine represents a significant advancement in antidepressant therapy, but the commonly used intravenous and intranasal application routes currently limit its availability beyond specialized centers. By contrast, oral ketamine treatment might constitute an alternative that is easy to administer with established safety and efficacy for patients with chronic and severe pain at home.

Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo

Cerebral Cortex September 6, 2018 Gregory M. James, Gregor Gryglewski, Thomas Vanicek et al. 16 citations

Parcellation of distinct areas in the cerebral cortex has a long history in neuroscience and is of great value for the study of brain function, specialization, and alterations in neuropsychiatric disorders. Analysis of cytoarchitectonical features has revealed their close association with molecular profiles based on protein density. This provides a rationale for the use of in vivo molecular...